Valuation: Berkley Renewables Inc.

Market Cap 364K 320K 299K 274K 513K 34.9M 526K 3.54M 1.39M 17.27M 1.37M 1.34M 59.71M P/E 2016
4.22x
P/E 2017 -1.16x
Enterprise Value 5.13M 4.5M 4.2M 3.86M 7.22M 491M 7.4M 49.85M 19.5M 243M 19.24M 18.83M 840M EV / Sales 2016
3.53x
EV / Sales 2017 3.18x
Free-Float
90.7%
Yield 2016 *
-
Yield 2017 -
Manager TitleAgeSince
Chief Executive Officer 63 20/06/2002
Director of Finance/CFO - -
Director TitleAgeSince
Chairman 63 -
Director/Board Member 66 17/08/2006
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 459K
+3.47%+0.48%+21.69%+1.84% 139B
+4.61%+3.16%+48.87%+63.34% 92.18B
+4.51%+1.74%+19.97%+11.66% 74.38B
+4.64%-0.34%+32.29%+36.73% 53.54B
+3.89%-0.83%+23.01%-9.75% 53.64B
+4.53%+0.57%+98.11%+63.39% 51.88B
+4.22%+0.82%+30.42%-16.11% 49.2B
+1.39%+4.77%+25.01%-13.89% 42.83B
+1.76%+5.56%+1.27%+24.34% 32.31B
Average +3.44%-1.13%+33.40%+17.95% 58.9B
Weighted average by Cap. +3.99%-1.72%+33.39%+18.83%

Financials

2016 2017
Net sales 1.03M 909K 848K 778K 1.46M 99.04M 1.49M 10.06M 3.93M 49.01M 3.88M 3.8M 169M 1.72M 1.52M 1.41M 1.3M 2.43M 165M 2.49M 16.78M 6.56M 81.75M 6.48M 6.34M 283M
Net income 173K 152K 142K 130K 243K 16.54M 249K 1.68M 657K 8.19M 648K 634K 28.3M -631K -554K -517K -475K -888K -60.39M -910K -6.13M -2.4M -29.88M -2.37M -2.32M -103M
Net Debt 2.92M 2.56M 2.39M 2.2M 4.11M 279M 4.21M 28.37M 11.1M 138M 10.95M 10.71M 478M 4.76M 4.18M 3.91M 3.58M 6.71M 456M 6.87M 46.31M 18.11M 226M 17.88M 17.49M 780M
Logo Berkley Renewables Inc.
Berkley Renewables Inc. is a Canada-based, growth-oriented diversified issuer also pursuing renewable energy opportunities, primarily in the solar energy sector. The Company is pursuing solar energy investments in Ontario, Canada. It is also engaged in developing autologous cell therapies to treat conditions linked to a deficit of healthy cells required for normal healing and function through RepliCel Life Sciences Inc. The Company's RCT-01, RCS-01, and RCH-01 cell therapies are designed to treat chronic tendinosis, damaged or aged skin and pattern baldness. The Company is also developing a proprietary injection device (RCI) for optimal clinical delivery. The Company is developing solar photovoltaic (PV) projects in Ontario, Canada, through its subsidiary, Solar Flow-Through General Partnership. Working with Solar Flow-Through, the Company has also developed a flow-through investment vehicle for investors to participate in Ontario's solar energy growth.
Employees
-